Request Trial
panel-1-latest-developments-from-the-upc
14 May 2026VideosUnified Patent CourtZoe Butler, Powell Gilbert | Penny Gilbert, Powell Gilbert

WATCH: Latest developments from the UPC

Are life sciences cases gaining momentum in the new Unified Patent Court? This session provides a critical update on the UPC's evolving jurisprudence, looking at emerging legal tests and the specific challenges of preliminary injunctions for life sciences products.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Unified Patent Court
WATCH: Navigating parallel EPO and UPC revocation actions: strategies, opportunities, and risks
23 May 2026   Managing parallel revocation actions requires a meticulous approach to forum choice and sequencing. This presentation unpacks the lessons learned from the first year of simultaneous EPO and UPC proceedings, offering tactics to leverage opportunities and minimise cross-border risks.
Unified Patent Court
WATCH: Facilitating access to the UPC—economics and navigating the UPC-US patent nexus
15 May 2026   Understanding the economic mechanisms and cross-border interactions of the UPC is crucial for modern patent litigation. This session untangles the complexities of evidence gathering and cost security, highlighting the critical interplay between European proceedings and US patent strategies.
Unified Patent Court
Regeneron and CureVac: UPC ‘cannot be ignored’
4 November 2025   Growing clout, powerful remedies, and efficiency are making the UPC a game-changer in global litigation, according to LSPN Europe experts. Tom Phillips reports.


Editor's picks

Where Big Pharma is betting big in the M&A boom
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026

Editor's picks

Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026
Regulation & Industry
Why is 2026 already a record year for M&A activity?
17 July 2026
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026
Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026
Biotech
Pfizer’s US Paxlovid patent fight turns on a single error
25 June 2026
Regulation & Industry
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026

More features

Kirkland clears conflicts hurdle in trade secrets spat
Former senior attorney-advisor to ITC commissioners joins Mintz
The UPC plugs another gap in its procedural rulebook
Novo’s Dutch win sends ‘clear message’ to unapproved semaglutide sellers
Brown Rudnick lands largest lateral IP team hire in firm history
Fran Salisbury: ‘There’s nothing quite like finding the missing piece’
K&L Gates expands European practice with Munich team hire
Patent litigator joins Baker Botts in London as UPC grows in significance